Medical devices, healthcare technology and the business of care
510(k) clearance · K261345

Pediatric Nailing Platform Femur

ORTHOPEDIATRICS CORP. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK261345

What did the FDA decide?

FDA's September 24, 2026 letter for K261345 records a substantial-equivalence determination for OrthoPediatrics Corp.'s Pediatric Nailing Platform | Femur. The summary describes nails, screws, end caps and condylar nuts made in 316L stainless steel or Ti-6Al-4V ELI titanium alloy, with antegrade and retrograde nail configurations. FDA lists Class II, regulation 888.3020 and product code HSB.

The summary's technological comparison specifically names K250623 as the predicate Pediatric Nailing Platform | Femur. Its predicate section also lists K220679 and K172583 for that device family, a DePuy Synthes secondary predicate and a Pega Medical reference device. These roles are distinct. The summary reports mechanical evaluations under ASTM F543 and F1264, but the available excerpts do not identify every technological difference or give numerical test results. This account reports the documented device and comparison structure without treating each listed clearance as the same predicate.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 24, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261345
Regulatory pathway
510(k) premarket notification
Product code
HSB
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Rod, Fixation, Intramedullary And Accessories.

Product code
HSB
FDA device class
2

FDA decision timeline

  1. K261345 received

    Application receipt date recorded by FDA.

  2. K261345 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HSB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

ORTHOPEDIATRICS CORP.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Warsaw, IN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records